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Improving clinical cognitive testing
Report of the AAN Behavioral Neurology Section Workgroup
ABSTRACT
Objective: To evaluate the evidence basis of single-domain cognitive tests frequently used by
behavioral neurologists in an effort to improve the quality of clinical cognitive assessment.
Methods: Behavioral Neurology Section members of the American Academy of Neurology were
surveyed about how they conduct clinical cognitive testing, with a particular focus on the Neuro-
behavioral Status Exam (NBSE). In contrast to general screening cognitive tests, an NBSE con-
sists of tests of individual cognitive domains (e.g., memory or language) that provide a more
comprehensive diagnostic assessment. Workgroups for each of 5 cognitive domains (attention,
executive function, memory, language, and spatial cognition) conducted evidence-based reviews
of frequently used tests. Reviews focused on suitability for office-based clinical practice, includ-
ing test administration time, accessibility of normative data, disease populations studied, and
availability in the public domain.
Results: Demographic and clinical practice data were obtained from 200 respondents who re-
ported using a wide range of cognitive tests. Based on survey data and ancillary information,
between 5 and 15 tests in each cognitive domain were reviewed. Within each domain, several
tests are highlighted as being well-suited for an NBSE.
Conclusions: We identified frequently used single-domain cognitive tests that are suitable for an
NBSE to help make informed choices about clinical cognitive assessment. Some frequently used
tests have limited normative data or have not been well-studied in common neurologic disorders.
Utilizing standardized cognitive tests, particularly those with normative data based on the individ-
ual’s age and educational level, can enhance the rigor and utility of clinical cognitive assessment.
Neurology® 2015;85:910–918
GLOSSARY
AAN 5 American Academy of Neurology; AD 5 Alzheimer disease; BIT 5 Behavioral Inattention Test; BNS 5 Behavioral
Neurology Section; BNT5 Boston Naming Test; CERAD5Consortium to Establish a Registry in Alzheimer’s Disease; FAB5
Frontal Assessment Battery; FTLD 5 frontotemporal lobar degeneration; HVLT-R 5 Hopkins Verbal Learning Test–Revised;
JLO 5 Judgment of Line Orientation; MMSE 5 Mini-Mental State Examination; MoCA 5 Montreal Cognitive Assessment;
NBSE5Neurobehavioral Status Exam; ROCFT5 Rey-Osterrieth Complex Figures Test; TBI5 traumatic brain injury; TMT5
Trail Making Test; UCNS 5 United Council for Neurologic Subspecialties; WAB-R 5 Western Aphasia Battery–Revised.
Cognitive testing is essential for evaluating memory and other cognitive complaints associated
with neurologic disorders. General cognitive tests, such as the Montreal Cognitive Assessment
(MoCA),1 Addenbrooke’s Cognitive Examination–Revised,2 or Mini-Mental State Examination
(MMSE),3 are useful for screening but have limited diagnostic specificity. By contrast, a Neuro-
behavioral Status Exam (NBSE)4 is a collection of cognitive tests, chosen by a neurologist,
intended to provide a more in-depth assessment of multiple cognitive domains, usually in
*These authors contributed equally to this work.
From the Center for Brain/Mind Medicine (K.R.D., S.A.G., A.C.P.), Division of Cognitive and Behavioral Neurology, Department of Neurology,
Brigham and Women’s Hospital, Harvard Medical School, Boston, MA; Kessler Foundation Research Center (A.M.B.), West Orange, NJ;
Department of Neurology (B.F.B.), Mayo Clinic, Rochester, MN; Department of Neurology and Center for Cognitive Neuroscience (A.C., H.B.C.),
University of Pennsylvania, Philadelphia; Helen Wills Neuroscience Institute (M.D.), University of California, Berkeley; Department of Neurology
(G.R.F.), University of Florida College of Medicine, Gainesville; Department of Neurology (D.R.G.), Northwestern University, Feinberg School of
Medicine, Chicago, IL; Center for Brain Health (J.J.H.), School of Behavioral & Brain Sciences, University of Texas at Dallas; Department of Neurology
(A.J.L.), University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH; Department of Neurology
and Neurological Sciences (K.J.M.), Stanford Comprehensive Epilepsy Center, Stanford University School of Medicine, CA; Western Institute for
Neurodevelopmental Studies and Interventions (K.S.V.), Boulder, CO; and Memory Disorders Program (D.I.K.), UNC Department of Neurology,
University of North Carolina at Chapel Hill.
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
910 © 2015 American Academy of Neurology
ª 2015 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.
conjunction with a neurologic evaluation, and
sometimes as a separate assessment procedure
(Current Procedural Terminology [CPT]
96116). If neuropsychology services are
unavailable, the NBSE is an essential compo-
nent of diagnostic assessment. If neuropsychol-
ogy testing services are available, the NBSE
may be still be useful as an adjunct or to help
in determining whether more in-depth testing
is needed, particularly for evaluating personality
and psychological traits. In general, the NBSE
is used to identify a patient’s pattern of relative
cognitive strengths and weaknesses, inform dif-
ferential diagnosis, and guide therapeutic man-
agement. However, there are no guidelines for
selecting tests for NBSE testing and virtually no
information about how the NBSE is deployed
in clinical practice. An NBSE differs from a
formal neuropsychological assessment in its
brevity, integration with other findings of a
broader neurologic evaluation, and absence of
formal intelligence testing or detailed assess-
ment of personality or psychological attributes.
Many neurologists do not consider norma-
tive values for tests, and neurologists often use
cognitive tests without ample normative data
or that have not been studied in the conditions
they are using them to assess. The NBSEWork-
group of the American Academy of Neurology
(AAN) was established to review office-based
cognitive testing in clinical practice as a refer-
ence point for quality improvement. Toward
this end, behavioral neurologists were surveyed
about their use of cognitive testing in clinical
practice. A large sample of frequently used tests
was reviewed in a standardized way, emphasiz-
ing desirable features for office-based testing:
brief administration time (total NBSE duration
of 30–60 minutes or less), diseases studied
(diagnostic utility), existence of normative val-
ues (normal, abnormal, borderline), and avail-
ability in the public domain (accessibility and
low cost). While not an exhaustive, systematic
review, characterizing how the NBSE is used in
clinical practice helped identify a compendium
of tests most suitable for domain-specific, nor-
mative, office-based testing to improve the qual-
ity and utility of cognitive testing.
METHODS NBSE practice survey. The executive council of
the Behavioral Neurology Section (BNS) of the AAN formed a
workgroup to evaluate the NBSE. The workgroup identified 5
main cognitive domains by consensus and assigned leaders for
each: attention (D.G.), executive function (K.D.), language
(J.H.), memory (D.K.), and spatial cognition (A.M.B.). Between
5 and 15 tests within each cognitive domain were chosen by each
subgroup to include in the survey (table 1). Tests that assess
multiple domains (e.g., Clock-Drawing Test) were assigned to a
single domain for review purposes.
A web-based survey using Google Documents was e-mailed
to all 713 members of the AAN-BNS in March 2012, inquiring
about the frequency of use of these selected tests and any addi-
tional tests that members administer. Respondents rated each test
as “often use,” “occasionally use,” or “never use.” The survey also
asked about time devoted to testing, patient populations evalu-
ated, and whether global cognitive screens (e.g., MMSE, Adden-
brooke’s Cognitive Examination–Revised), neuropsychiatric
scales (e.g., Neuropsychiatric Inventory),5 and functional rating
scales (e.g., Functional Activities Questionnaire)6 are also admin-
istered. A more detailed account of the survey data will be con-
veyed in a separate report.
Evidenced-based review. Tests that survey respondents indi-
cated were either “often” or “occasionally” used were selected
for review. Each cognitive domain subgroup used PubMed, Ovid,
and textbooks to review the literature on the included tests. Each
test review followed a similar format: (1) historical background
and test description; (2) specific cognitive functions assessed; (3)
copyright status (restricted or public domain); (4) administration
time; (5) normative data across the adult lifespan; (6) patient
populations studied; (7) advantages/limitations of the test; and
(8) key references.
RESULTS Survey. Two hundred of the 713 AAN-
BNS members (28%) responded to the survey
(table 2). Most respondents (87%) were board-
certified in Neurology and 22% had United Council
for Neurologic Subspecialties (UCNS) certification
in the Behavior Neurology & Neuropsychiatry
subspecialty. The majority of respondents (79%) were
adult neurologists and most (72%) were US-based.
Review. Data compiled for each test were used to create
37 summary tables, which are included in appendix e-1
on the Neurology® Web site at Neurology.org. Table 3
provides an example of a summary table, in this case for
the Trail Making Test (TMT). These tables cover
administration time, variations of the test used, a
focused review of validity, normative data, some
limited psychometric properties, and a consensus
summary of the test’s benefits and shortcomings. The
data are intended to provide a concise reference guide to
the clinical neurologist, in contrast to a comprehensive
review of test characteristics and psychometric properties
contained in neuropsychology textbooks.7,8 Table 4
highlights some of the reviewed tests and summarizes
whether each has properties that the workgroup believes
may be important for test selection in clinical practice
(e.g., available normative values; a brief administration
time; availability in the public domain).
Attention domain tests. Tests of attention can be
broadly divided into 2 groups: “basic” or “complex”
attention. Basic attention is a prerequisite for all other
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mental functions and reflects the ability to sustain
focus in order to perform a simple task. Complex
attention reflects the ability to control, shift, and
divide attentional focus, allowing for the manipula-
tion of information and execution of multiple steps to
accomplish a goal. Among tests of attention, all but
the 3 continuous performance tests and some versions
of the Stroop Test are not copyright-restricted (i.e., in
the public domain).
Digit Span Forward9 and TMT, Part A
(TMT-A)10 are frequently used tests of basic atten-
tion. The former assesses maintenance aspects of
working memory and TMT-A indexes processing
speed. These tests are brief, have robust normative
values across the adult lifespan, and have been broadly
studied in patients with Alzheimer disease (AD) and
other cognitive disorders.11,12 The Corsi Blocks Test13
involves imitating sequential tapping patterns on
blocks arrayed on a board. The longest sequence
(i.e., number of blocks) tapped correctly is a measure
of spatially mediated attentional capacity. The test is
easy to administer and has been widely studied,14 but
scoring schemes are not well standardized.15
TMT, Part B (TMT-B), Months-of-the-Year-
Backward, and the Stroop Test are complex attention
tasks that are accessible in the public domain and have
age-adjusted normative values across the adult life-
span.16–18 TMT-B is a timed test in which patients
are asked to alternately connect circled numbers and
letters that are irregularly distributed across a page. It
requires planning, sequencing, set-shifting, and
response-inhibition. Months-of-the-Year-Backward is
a Sequential Operations Series test in which a patient
is asked to recite an overlearned sequence in reverse
order. It can serve as a brief assessment of complex
attention and working memory, and may also be use-
ful for tracking change if administered as a timed test.
Executive domain tests. Tests of executive function range
from assessing set-shifting and inhibitory control, to
evaluating higher-order conceptual skills and abstract
reasoning. Among tests reviewed, only some versions
of the Proverbs Test19 and the Similarities subtest of
the Wechsler Adult Intelligence Scale20 were copyright-
restricted. The antisaccade task, which examines the
ability to inhibit automatic motor behavior by exerting
control over the strong tendency to look toward a visual
stimulus, takes 3 minutes or less, has normative values
throughout the lifespan,21 and has been validated in
tracking AD progression.22 It has also been studied in
different subtypes of mild cognitive impairment,23
progressive supranuclear palsy, schizophrenia,24 and
frontotemporal lobar degeneration (FTLD).25
The Frontal Assessment Battery (FAB) includes 6
tasks that range from motor control programs to
higher-order concept formation and interpretation.26
Table 1 Tests reviewed by cognitive domain
Attention






Paced Auditory Serial Addition Test (PASAT)
Sequential Operation Series
Stroop
Trail Making Test, Parts A and B
Executive
Antisaccade
Frontal Assessment Battery (FAB)





Boston Naming Test (BNT)
Boston Naming Test (BNT)–15-Item Short Form
Controlled Oral Word Association Test (COWAT)
Semantic Category Fluency
Western Aphasia Battery–Revised (WAB-R)
Memory
California Verbal Learning Test (CVLT)
CERAD Word-List Memory
Hopkins Verbal Learning Test–Revised (HVLT-R)
Logical Memory Test (I and II)
NYU Paragraph Recall
Rey Auditory Verbal Learning Test (RAVLT)
Verbal Paired Associates
Spatial cognition





Judgment of Line Orientation (JLO)
Line bisection tests
Navon Figures
Rey-Osterrieth Complex Figures Test (ROCFT)
Abbreviations: CERAD 5 Consortium to Establish a Regis-
try in Alzheimer’s Disease; D-KEFS 5 Delis-Kaplan Execu-
tive Function System; NYU5 New York University; WAIS-IV
5 Wechsler Adult Intelligence Scale–Fourth Edition.
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It has robust age- and educational-based normative
data, is not copyright-restricted, and has been used in
FTLD, AD, and Parkinson disease.27 Higher-order
executive functions, including abstract thinking and
concept formation, can also be assessed with the Sim-
ilarities subtest of the Wechsler Adult Intelligence
Scale–Fourth Edition28 and the Proverbs Test of the
Delis-Kaplan Executive Function System.19 These
tests may be useful as an adjunct to the FAB.
Language domain tests. Language tests were reviewed
covering naming, comprehension, reading, writing,
speech production, verbal fluency, and semantic-
lexical retrieval. Of the 5 tests reviewed, only the
Semantic/Category Fluency test is in the public domain.
Verbal fluency is often assessed by the ability to
generate words based on semantic category (semantic
fluency) or first letter (phonemic/lexical fluency). The
semantic fluency test reviewed is part of several lan-
guage batteries, including the Boston Diagnostic
Aphasia Examination29 and the Western Aphasia
Battery–Revised (WAB-R).30 Patients are asked to list
as many exemplars of a specified category (e.g., animals,
fruits) as possible in 1 minute. Normative values across
the adult lifespan exist for several common catego-
ries.31,32 This test has been studied in longitudinal co-
horts of aging and patients with AD at various stages of
severity.33,34 Impaired semantic processing, as indexed
by reduced semantic fluency, is a common early sign
of underlying AD pathology.35 The Controlled Oral
Word Association Test,36,37 a phonemic fluency task
in which patients generate words from a letter cue
(e.g., “F”), also has age- and education-adjusted norms
across the adult lifespan38 and has been studied in mul-
tiple conditions.33,34,39,40 The WAB-R is a 45- to 60-
minute battery that examines the major aspects of
language (e.g., comprehension, writing, fluency) and
has ample normative data and validity in detecting
and tracking language impairment in many disor-
ders.e1,e2 Although the length of the WAB-R makes it
impractical for brief testing, there is a “BedsideWAB-R”
tool that screens for major aspects of language dysfunc-
tion, takes only 15 to 20 minutes to administer, and has
separate normative values.e3
The Boston Naming Test (BNT)–15-Item Short
Forme4 is one of several abbreviated versions of the
BNT,e5 a visual confrontation naming test. The BNT
has been investigated for use in neurodegenerative
diseases (e.g., AD, FTLD), vascular dementia, multi-
ple sclerosis, and epilepsy and may be useful for the
longitudinal tracking of aphasia due to multiple etio-
logies.e6 Performance on many BNT-15 versions,
composed of different subsets of the original BNT
stimuli,e7 is highly correlated with the full 60-item
BNT.e8 In addition to the existence of normative data
for older adults (50s to 90s),e8 this feature makes the
BNT-15 useful for brief evaluation like the NBSE.
Memory domain tests. All tests reviewed were verbally
based auditory memory tests. Several tests (e.g., Rey-
Osterrieth Complex Figures Test [ROCFT])e9
discussed in the attention and spatial cognition
sections have visual-based memory components.
Among the 7 tests reviewed, only the Consortium to
Establish a Registry in Alzheimer’s Disease (CERAD)
Word-List Memory Teste10 and the Rey Auditory
Verbal Learning Teste9 are in the public domain. The
CERAD is a 10-word list of unrelated words that
includes 3 learning trials, followed by a delayed recall
and forced-choice recognition trial. The test has ample
normative values for ages 50 to 90, is validated in
several longitudinal AD trials, and has a relatively
brief administration time.e8–e10 The Hopkins
Verbal Learning Test–Revised (HVLT-R)e11 is
another relatively brief 12-word list that contains 4
words from each of 3 categories (e.g., gems). This
“semantic clustering” provides an opportunity to use
associative learning as a strategy for encoding and
retrieving words. The HVLT-R has been studied
in a number of conditions, including vascular
dementiae12 and traumatic brain injury (TBI).e13
Another approach to assessing verbal memory is the
recall of prose passages. Learning and storing informa-
tion that is part of a colorful narrative text is often less
demanding than memorizing a list of unrelated words.
Assessing both can provide multiple perspectives on
the severity of memory deficits. The Logical Memory
I and II subtests of the Wechsler Memory Scalee12 have
robust normative values for ages 16 to 90e12 and,
Table 2 Demographics of the 200 survey respondents (members of the
AAN-BNS)





Neurology (ABPN or NE) 164 (82)
Psychiatry (ABPN or NE) 7 (4)
Neurology and Psychiatry (ABPN or NE) 9 (5)
Neurology, with special qualification Child Neurology 8 (4)
No reply or other certifications (Internal Medicine, Geriatrics) 12 (6)
Behavioral Neurology & Neuropsychiatry (UCNS) 44 (22)
Time spent for new patient on NBSE (n 5 129 responded), n (%)
21–30 min 28 (22)
>30 min 101 (78)
Abbreviations: AAN-BNS5 American Academy of Neurology–Behavioral Neurology Section;
ABPN 5 American Board of Psychiatry and Neurology; NBSE 5 Neurobehavioral Status
Exam; NE 5 national equivalent; UCNS 5 United Council for Neurologic Subspecialties.
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Table 3 Example of a summary table from the evidenced-based review
Test name Trail Making Test
Description A brief, 2-part test of basic attention and working memory. The original Trail Making Test (TMT) was
developed by a team of US Army psychologists as part of the Army Individual Test Battery (1944).1
Different administration and scoring systems were subsequently introduced. It has developed into
a widely used instrument, with versions incorporated into the Delis-Kaplan Executive Function
System (D-KEFS)2 and the Halstead-Reitan Battery (HRB).3
In Part A (TMT-A), the patient draws lines connecting consecutively numbered circles. In Part B
(TMT-B), the patient draws lines alternating between circles containing numbers and circles
containing letters, fulfilling a specific, alternating sequence (i.e., 1-A, 2-B, 3-C). The measured value
is the time to completion for each part. In some adapted versions, such as the HRB, the examiner
notes errors and points them out to the patient during the test. Other factors that might affect
performance are visual scanning and motor speed.
Specific functions assessed Attention/visual scanning, motor speed, working memory
Subscales Of the common versions, the D-KEFS involves 5 subscales:
Visual Scanning. This is a cancellation task in which the patient is asked to identify and cross out
a specific target on an 1199 3 1799 page. This test would also serve to identify hemispatial
neglect. Omission/commission errors are included in the scoring as well as time to complete.
Number Sequencing. This is a number sequencing task (similar to TMT-A).
Letter Sequencing. This involves connecting letters of the alphabet in sequence.
Number-Letter Switching. The patient is asked to draw lines, switching between numbers and
letters in sequence (e.g., 1-A, 2-B). This is the primary executive function task, similar to TMT-B.
Motor Speed. The patient traces over a line connecting a series of circles.
Number of items/scoring On the 2-part TMT, the times to completion for A and B are recorded and the difference of time to
completion on B minus A is used as the variable and compared with norms. A large B minus A
difference reflects attentional difficulties and/or problems with working memory. An alternative
computation involves the ratio B/A, but this is thought to be less reliable.4
Copyright status Copyrighteda and public domainb
Administration time Variable depending on the version and type of patient, typically 5–20 min.
Normative psychometric
data
Norms are specific to the version. Ample norms are available for ages 18–89 years.5 The D-KEFS
version provides age-based norms for each of the 5 subtests (listed above). Norms for ages 8–89
years are provided for each subscale task and error analysis. In addition to time-completion scores,
error scores for sequencing errors vs set-loss error scores are provided. Contrasts between
performances on the various subscale tasks (with norms) are also provided.
Sensitivity and specificity Vary across versions. Performance on the TMT, particularly Part B, correlates with reduced driving
performance6,7 and mobility impairment with aging.8 The TMT has also been used in studies of
Huntington disease9 and traumatic brain injury,10 among other disorders.
Advantages Sensitive measure of sustained attention, attentional control, and set-shifting, which has been
widely applied to various disorders (e.g., attention deficit disorder). Careful observation of the way
patients approach the task, the type of errors they make, and analysis of the type of errors
contribute to the test’s value.
Limitations Task performance is affected by a number of factors (e.g., age, educational status) in addition to
neurocognitive issues. These need to be factored into the analysis.11,12
References 1. Army Individual Test Battery. In: War Department, editor. Manual of Directions and Scoring.
Washington, DC: Adjutant General’s Office; 1944.
2. Delis DC. Delis-Kaplan Executive Function System (D-KEFS). San Antonio: The Psychological
Corporation; 2001.
3. Lezak MD. Neuropsychological Assessment, 3rd ed. New York: Oxford University Press; 1995.
4. Martin TA, Hoffman NM, Donders J. Clinical utility of the Trail Making Test ratio score. Appl
Neuropsychol 2003;10:163–169.
5. Tombaugh TN. Trail Making Test A and B: normative data stratified by age and education. Arch
Clin Neuropsychol 2004;19:203–214.
6. Emerson JL, Johnson AM, Dawson JD, Uc EY, Anderson SW, Rizzo M. Predictors of driving
outcomes in advancing age. Psychol Aging 2012;27:550–559.
7. Hargrave DD, Nupp JM, Erickson RJ. Two brief measures of executive function in the prediction
of driving ability after acquired brain injury. Neuropsychol Rehabil 2012;22:489–500.
8. Vazzana R, Bandinelli S, Lauretani F, et al. Trail Making Test predicts physical impairment and
mortality in older persons. J Am Geriatr Soc 2010;58:719–723.
9. O’Rourke JJ, Beglinger LJ, Smith MM, et al. The Trail Making Test in prodromal Huntington
disease: contributions of disease progression to test performance. J Clin Exp Neuropsychol
2011;33:567–579.
Continued
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together, take about 10 minutes to complete, with a
suggested 20-minute delay. Performance on Logical
Memory correlates with outcomes in several neuropsy-
chiatric settings, including recovery from TBI,e13 social
functioning in schizophrenia,e14 and the ability to com-
prehend and reason about treatment decisions in mild
to moderate AD.e15
Various 3-word and 5-word recall tests were not
reviewed in this study. There are limited normative
data for these tests and recall performance varies
widely depending on the words used and whether pa-
tients are instructed to remember the words. The
recall of 0 or 1 of 3 words presented may be a “red
flag” for memory impairment in adults aged 65 to 90













Trail Making Test, A and B 5–10 O O O
Digit Span Forward 3–5 O O O
Digit Span Backward 3–5 O O O
Sequential Operation Series (e.g.,
Months-of-the-Year-Backward)
3 (per task) O O
Stroop 7–10 O O O
Executive
Antisaccade 3 O O O
Similarities subtest (WAIS-IV) 3–5 O O
Frontal Assessment Battery 10 O O O
Clock-Drawing Test 3–7 O O O
Language
Boston Naming Test–15-Item Short Form 3–5 O
Controlled Oral Word Association 5 O O
Semantic Category Fluency 5 O O O
Memory
CERAD Word-List Learning 5–10 O O
Hopkins Verbal Learning Test 5–10 O O
Rey Auditory Verbal Learning Test 15 O O O
Spatial cognition
Short-forms JLO 10 O O
Cube Copying Test 2–3 O O
Cancellation Test 3–5 O O
Line bisection test 1–2 O
Abbreviations: CERAD 5 Consortium to Establish a Registry in Alzheimer’s Disease; JLO 5 Judgment of Line Orientation;
WAIS-IV 5 Wechsler Adult Intelligence Scale–Fourth Edition.
Table 3 Continued
Test name Trail Making Test
10. Perianez JA, Rios-Lago M, Rodriguez-Sanchez JM, et al. Trail Making Test in traumatic brain
injury, schizophrenia, and normal ageing: sample comparisons and normative data. Arch Clin
Neuropsychol 2007;22:433–447.
11. Bornstein RA, Suga LJ. Educational level and neuropsychological performance in healthy
elderly subjects. Dev Neuropsychol 1988;4:17–22.
12. Stuss DT, Stethem LL, Pelchat G. Three tests of attention and rapid information processing: an
extension. Clin Neuropsychol 1988;2:246–250.
a The D-KEFS is copyrighted and commercially available.
b The original Trail Making Test5 and Halstead-Reitan adapted version are in the public domain.
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years, as suggested by the Mini-Cog screening test.e16
However, up to 19% of older adults who recall only
1 word on a 3-word test perform normally on more
detailed memory testing, suggesting that these simple
tests may not accurately reflect a patient’s memory
function.e16,e17
Spatial cognition domain tests. Nine tests in this
domain were reviewed, including tests of visuoper-
ceptual processing; visuoconstructive ability (which
depends on organization and planning); and spatial
bias processing associated with spatial inattention,
neglect syndromes, or simultanagnosia. Most of the
spatial cognition tests reviewed are in the public
domain, except the Behavioral Inattention Test
(BIT)e18 and the Benton Judgment of Line Orienta-
tion (JLO).e19
Among visuoconstructive tests, the Clock-
Drawing Test is well-suited for an NBSE. It is brief,
has abundant normative datae20,e21 (although based on
several different scoring criteria), and is validated in
stroke, AD, and a range of psychiatric disorders.e22–e24
It has been used for decades to both detect and serially
grade disease severity in degenerative dementias.e25–e27
The Cube Copying Test, also a part of the Short Test
of Mental Statuse28 and the MoCA, involves copying
a 3-dimensional cube. Although typically scored as
correct/incorrect, several quantitative scoring meth-
ods are available.e29,e30 The JLOe19 is useful for iden-
tifying visuoperceptual deficits in judging spatial
relationships. There are several short forms of the
JLO that utilize a subset of the stimuli and signifi-
cantly reduce administration time but are also
copyright-protected.e31 Performance on short forms
of the JLO generally correlates well with full JLO
scores.e31 Normative values for both the JLOe32 and
some frequently used short formse33 are available, par-
ticularly for ages 50 to 90.
Visual cancellation testse34 assess visual scanning
strategies and spatial bias and may be a useful com-
ponent of an NBSE. Typically, patients are asked to
mark each occurrence of target stimuli that are scat-
tered across a page containing distracter items. Many
versions of this brief test are in the public domain,
and some have normative values across the adult life-
span.e35 Line bisection tests are easy to administer and
also provide a straightforward assessment of spatial
bias. Both cancellation and line bisection tests have
been well studied and validated in patients with hemi-
spheric lesions due to stroke or tumors.
The BITe18 and ROCFTe9 examine spatial cogni-
tive processes, but may be challenging to include in
an office-based NBSE. The BIT is lengthy, has lim-
ited normative values across the adult lifespan, and is
copyright-protected. The ROCFT complements ver-
bal memory tests by assessing the acquisition and
storage of visual (nonverbal) information, and has
abundant normative values.e36 Drawbacks include
lengthy administration time and potential confound-
ing by organizational and planning deficits.
DISCUSSION Cognitive testing by behavioral neu-
rologists often entails a mixture of relatively brief cog-
nitive tests, such as 3-word memory recall or a motor
Go/No Go test, and abbreviated versions of
neuropsychological assessments or subtests of test
batteries. Whereas the former may be informative
in some clinical contexts, tests that lack
standardized administration and scoring guidelines
have less utility for an NBSE. The tests reviewed
varied considerably in terms of available normative
data and information on their use in specific patient
populations (e.g., AD, TBI). Some tests (e.g.,
cancellation, Luria Hand-Sequencing) do not have
available normative values to use for office-based
reference and scoring.
Relevance to clinical practice: Toward evidence-based
NBSE. The availability of age- and education-
appropriate normative values may be the most
important test characteristic to help accurately
interpret a patient’s performance. Given the wide age
range of adults seeking neurology evaluations, tests
with normative values across the adult lifespan are
often most helpful. Many normative values are
published and some relevant citations for each test
are in appendix e-1. Although test choice should
ideally be based on psychometric validity for the
symptoms being assessed, both the cost and limited
access of copyrighted tests may be nontrivial barriers
for many practices. Tests used in an NBSE, especially
those that are subtests of neuropsychological batteries,
generally require formal training in test administration,
scoring, and interpretation, with provision for expert
guidance and feedback during the learning phase.
As a reference guide for the NBSE, this review is
intended to help neurologists better assess major cog-
nitive domains with tests that are most appropriate
for evaluating hypotheses about a given patient.
The pattern of impairments can suggest which neural
networks may be disrupted. Along with the available
history, neurologic examination, and laboratory or
imaging data, this can help to identify the likely
underlying pathologic process. For example, a profile
of deficits in memory storage, semantic fluency, and
complex attention suggests disruption of temporolim-
bic structures (e.g., hippocampus), temporal neocor-
tex, and frontal networks. In a 75-year-old patient
with progressive deficits but no functional decline,
this pattern suggests a diagnosis of mild cognitive
impairment, amnestic subtype, which often reflects
underlying AD pathology.
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Our review suggests some incongruence between a
few widely used tests and those that we suggest may
be most optimal for an NBSE. For example, the Luria
Hand-Sequencing Test was reported as either often
used or occasionally used by more than two-thirds
of respondents. Although this test is brief and does
not require test materials, it has limited published
norms across the adult lifespan. The Luria test is a
component of several batteries (e.g., the FAB) for
which norms are available. Although a patient’s
inability to learn a Luria sequence or the tendency
to exhibit sustained, perseverative responses would
clearly represent impaired performance, judging
whether more subtle sequencing errors is abnormal
for age is much more challenging in the absence of
norms. Also, various 3- or 5-word memory recall tests
were reported as used often by more than half of
respondents. Although brief and often available in
the public domain, these frequently used bedside tests
have limited normative data and have been less stud-
ied in dementia populations than the word-list mem-
ory tests reviewed here.
Neuropsychological evaluation. An NBSE conducted
by neurologists may bring to light issues that would
benefit from a comprehensive neuropsychological
assessment. Such evaluations are much more exten-
sive (2–6 hours) than the typical 30- to 60-minute
NBSE and provide a more detailed, quantitative
assessment of cognitive function, particularly regard-
ing premorbid estimates of cognitive abilities. For
example, neuropsychological assessment may corrob-
orate or challenge results from an NBSE and help
track disease progression over time, provide feedback
to families about changes in the patient’s status, and
allow for the planning of cognitive rehabilitation pro-
grams. Neuropsychological evaluation may also be
helpful in patients who show borderline impairment
on an NBSE, are at either end of the educational
spectrum, have prominent psychiatric comorbidities,
or who may be involved in medicolegal action. In our
experience, collaboration between neurologists and
neuropsychologists often facilitates optimal diagnos-
tic and treatment plans for patients. It is essential that
clinicians be cognizant of practice effects if both an
NBSE and neuropsychological evaluation are com-
pleted in close succession.
Limitations. We reviewed a small number of the hun-
dreds of cognitive tests that have been developed.
Although our survey data helped identify the most
frequently used tests for review, our findings do not
preclude other available tests from being appropriate
for an NBSE. This may be particularly true for tests
that were not initially, or are not widely, used in
English. We did not review the tests “written-in” by
respondents as being used in addition to the surveyed
tests. Some of the tests evaluated have limited norma-
tive data across certain patient populations and do not
account for medication-related or practice effects. In
addition, the literature on cognitive testing is
extensive, and important findings for the reviewed
tests may have been inadvertently omitted.
In an effort to maintain brevity, we only summar-
ily reviewed the psychometric properties of individual
tests, and we urge clinicians to refer to comprehensive
neuropsychology texts as needed for additional infor-
mation about individual tests. We also did not specif-
ically address general cognitive tests such as the
MMSE or MoCA or how to integrate them into an
NBSE, both issues which are beyond the scope of this
report. Our survey sample rate was relatively low
(200/713, 28%) and only 44 of 200 respondents
(22%) were UCNS certified in Behavioral Neurology
& Neuropsychiatry. For the current report, the sur-
vey data were primarily used as a guide, along with the
authors’ consensus, for determining which tests
would be reviewed. This study provides a glimpse
into the current practice of formal and informal cog-
nitive testing among behavioral neurologists and pro-
vides an evidence-based review and a test selection
resource to help neurologists make informed choices
about testing. A large-scale and broader survey of
other subspecialty neurologists who perform cogni-
tive assessment in various settings would complement
this study. We also envision future studies that incor-
porate general screening tests and longitudinal follow-
up. This review of single-domain cognitive tests serves
as a starting point for quality improvement in clinical
cognitive assessment.
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